- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.01. | Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina | 171 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has... ► Artikel lesen | |
| 10.01. | Ikonisys SA: Ikonisys finalized a capital increase through the offsetting of debt | 205 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 31.12.24 | Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific | 262 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.12.24 | The Ikonisys Group Unveils its New Vision and Strategy Under the Brand "ALIKO SCIENTIFIC" | 271 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution... ► Artikel lesen | |
| 25.11.24 | Ikonisys SA: Ikonisys Group Secures Major Public Contract for Ikoniscope20 Robotic Microscope in Italy | 60 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 19.11.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 171 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 18.11.24 | Ikonisys SA: Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama | 275 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 12.11.24 | Ikonisys SA: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax's CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety | 339 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 04.11.24 | Ikonisys SA: Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories | 383 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 31.10.24 | Ikonisys SA: Ikonisys Publishes Its 2024 Half-Year Financial Results | 299 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 31.10.24 | Ikonisys Publishes Its 2024 Half-Year Financial Results | 95 | Business Wire | PARIS--(BUSINESS WIRE)--Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution... ► Artikel lesen | |
| 14.10.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 457 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 10.10.24 | Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Enna in Italy | 228 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancer through fully automated solutions for medical laboratories, is... ► Artikel lesen | |
| 03.10.24 | Successful 2024 ISO 13485 Certification Maintenance Strengthening Ikonisys' Strong Market Position and Growth Potential | 316 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 01.10.24 | Ikonisys Announces the Results of its Ordinary Annual and Extraordinary General Meeting of September 30, 2024 | 242 | Business Wire | Adoption of all resolutions submitted to the vote
Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through... ► Artikel lesen | |
| 12.09.24 | Ikonisys SA: Postponement of the Shareholders' Meeting to September 30, 2024 and Amendment of the Agenda | 214 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 11.09.24 | Ikonisys and BIO BRASIL BIOTECNOLOGIA to Strengthen Partnership to Expand Cytology Services in Brazil | 415 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 09.09.24 | Ikonisys SA: Ikonisys Announces the Launch of Ikoniscope Max in Europe at the 36th European Congress of Pathology in Florence | 206 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.09.24 | Ikonisys SA: Terms and Conditions of Availability of Preparatory Documents for the General Meeting of September 25, 2024 | 297 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 15.08.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 264 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
Seite:
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 53,78 | +3,22 % | Siemens Healthineers: Dieser Trading-Tipp war ein Treffer ohne Gewinn! | Im Express-Service hatten wir eine Short-Trade vorgeschlagen und das war der Hinweis für Abonneten: "Charttechnisch betrachtet bewegt sich der Kurs seit Ende Juli in einer breiten Seitwärtsbewegung... ► Artikel lesen | |
| FRESENIUS | 36,210 | -0,47 % | Fresenius SE Aktie: Zeichen stehen auf Gewinn | Die Fresenius SE-Aktie zeigt sich am Handelstag in robuster Verfassung und verzeichnet eine positive Entwicklung im XETRA-Handel. Das Wertpapier konnte im Tagesverlauf um 0,6 Prozent zulegen und erreichte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,340 | -0,36 % | Fresenius Medical Care Aktie: Richtung stimmt! | Die Fresenius Medical Care-Aktie setzt ihren positiven Trend fort und verzeichnet am 19. Januar 2025 einen Kursanstieg von 0,04 Prozent auf 44,88 EUR. Die Entwicklung der vergangenen Wochen zeigt eine... ► Artikel lesen | |
| GERRESHEIMER | 67,05 | +2,52 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 20,890 | +12,61 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 48,800 | +1,41 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 40 Euro auf "Underweight" belassen. Das erste Geschäftsquartal dürfte mau ausfallen... ► Artikel lesen | |
| ATRICURE | 39,630 | +3,02 % | AtriCure (NASDAQ:ATRC) Hits New 52-Week High - Should You Buy? | ||
| PROCEPT BIOROBOTICS | 69,72 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
| GENEDX | 74,33 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
| HIMS & HERS HEALTH | 28,680 | +0,31 % | DIESE AKTIE - Hims & Hers Health - handele ich heute! - Webinar mit Martin Goersch | ||
| UNITEDHEALTH | 503,70 | +0,02 % | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Check | In der neuesten Folge von "Money Train" begrüßen wir Martin Weiß, stellvertretender Chefredakteur bei DER AKTIONÄR. Gemeinsam analysieren wir die aktuelle Lage bei Intel, Intuitive Surgical und UnitedHealth... ► Artikel lesen | |
| RXSIGHT | 30,920 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| INTUITIVE SURGICAL | 580,00 | +0,07 % | Here's How Much $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth Today | ||
| DRAEGERWERK | 55,90 | +2,01 % | DZ BANK stuft Draegerwerk auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für die Vorzugsaktie von Drägerwerk von 53 auf 58 Euro angehoben und die Einstufung auf "Halten" belassen. Der Medizin- und Sicherheitstechnikhersteller... ► Artikel lesen | |
| PROGYNY | 21,470 | +2,29 % | Progyny beruft Gesundheitsexpertin Debra Morris in den Vorstand |
Das Unternehmen IKONISYS kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,29 % bei einem Aktienkurs von 1,530 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS finden Sie auf Wallstreet Online.
